Use Auxilium Pharmaceuticals Inc. story with your portfolios to enhance returns of your portfolios as well as to determine Stock diversification method that is right for you.
This story from stocks.us.reuters.com contributed to next trading day price decline. The story delta to the next closing price was 0.68% . The story delta to the current price is 19.18% .
By DOW JONES NEWSWIRES Auxilium Pharmaceuticals Inc. (AUXL) raised its full-year outlook as it entered an agreement with the US unit of GlaxoSmithKline PLC (GSK) to co-promote a testosterone replacement therapy.
Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline LLC Enter Into a Co ...
MarketWatch (press release) - 10 hours ago
MALVERN, Pa. and PHILADELPHIA, May 21, 2012 /PRNewswire via COMTEX/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) and GlaxoSmithKline LLC, the US subsidiary of GlaxoSmithKline plc (LSS:UK:GSK) , announced today that they have entered into an ...
Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss ... - Sacramento Bee
Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
USA 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Summary
Fundamentals
Technicals
Performance
Valuation
Volatility
History
News
Management
Discussion
